Inguinal lymph node metastases from prostate cancer: clinical, pathology, and multimodality imaging considerations
Open Access
- 1 January 2024
- journal article
- research article
- Published by FapUNIFESP (SciELO) in Radiologia Brasileira
- Vol. 57, e20240013
Abstract
Objective: To investigate clinical, pathology, and imaging findings associated with inguinal lymph node (LN) metastases in patients with prostate cancer (PCa). Materials and Methods: This was a retrospective single-center study of patients with PCa who underwent imaging and inguinal LN biopsy between 2000 and 2023. We assessed the following aspects on multimodality imaging: inguinal LN morphology; extrainguinal lymphadenopathy; the extent of primary and recurrent tumors; and non-nodal metastases. Imaging, clinical, and pathology features were compared between patients with and without metastatic inguinal LNs. Results: We evaluated 79 patients, of whom 38 (48.1%) had pathology-proven inguinal LN metastasis. Certain imaging aspects— short-axis diameter, prostate-specific membrane antigen uptake on positron-emission tomography, membranous urethra involvement by the tumor, extra-inguinal lymphadenopathy, and distant metastases—were associated with pathology-proven inguinal LN metastases (p < 0.01 for all). Associations with long-axis diameter, fatty hilum, laterality, and uptake of other tracers on positronemission tomography were not significant (p = 0.09–1.00). The patients with metastatic inguinal LNs had higher prostate-specific antigen levels and more commonly had castration-resistant PCa (p < 0.01), whereas age, histological grade, and treatment type were not significant factors (p = 0.07–0.37). None of the patients had inguinal LN metastasis in the absence of locally advanced disease with membranous urethra involvement or distant metastasis. Conclusion: Several imaging, clinical, and pathology features are associated with inguinal LN metastases in patients with PCa. Isolated metastasis to inguinal LNs is extremely rare and unlikely to occur in the absence of high-risk imaging, clinical, or pathology features.Keywords
This publication has 27 references indexed in Scilit:
- Stereotactic ablative body radiotherapy for oligometastatic inguinal lymph node in castrate resistant prostate cancerAsian Journal of Urology, 2023
- Prostate cancer recurring as small‐cell carcinoma with aBRCA2somatic mutationIJU Case Reports, 2022
- Introducing the Node Reporting and Data System 1.0 (Node-RADS): a concept for standardized assessment of lymph nodes in cancerEuropean Radiology, 2021
- PSMA-PET/CT–based Lymph Node Atlas for Prostate Cancer Patients Recurring After Primary Treatment: Clinical Implications for Salvage Radiation TherapyEuropean Urology Oncology, 2021
- Metastatic Prostate Cancer Presenting With Bilateral Inguinal LymphadenopathyClinical Genitourinary Cancer, 2019
- Imaging of Prostate Cancer Using FluciclovinePET Clinics, 2017
- A Better Understanding of Lymphatic Drainage of the Prostate With Modern Imaging and Surgical TechniquesClinical Genitourinary Cancer, 2013
- Distribution of metastatic sites in patients with prostate cancer: A population‐based analysisThe Prostate, 2013
- The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysisClinical Radiology, 2008
- Distribution of Lymph Nodes in Men with Prostatic Adenocarcinoma and Lymphadenopathy at Presentation: A Retrospective Radiological Review and Implications for Prostate and Pelvis RadiotherapyClinical Oncology, 2006